Patents/Inventors

Ekkehard Moessner

SchlierenCH38 patents

32 Patents

US126007812026
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US125901512026
Anti-human CD19 Antibodies with High Affinity
Hoffmann-la Roche Inc.
0 cites
US124733732025
Bispecific Antibody Molecules Binding to CD3 and Egfrviii
Hoffmann-la Roche Inc.
0 cites
US124668892025
Anti-hla-g Antibodies and Use Thereof
Hoffmann-la Roche Inc.
0 cites
US124418122025
Methods of Treating Cancer by Administering Tumor Necrosis Factor (TNF) Family Ligand Trimer-containing Antigen-binding Molecules
Hoffmann-la Roche Inc.
0 cites
US123311342025
Trispecific Antibodies Specific for HER2 and a Blood Brain Barrier Receptor and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US122972632025
Humanized Anti-tau(ps422) Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US122915612025
Antigen Binding Receptors Specific for Mutated Fc Domains
Hoffmann-la Roche Inc.
0 cites
US122864862025
Anti-fap Antibodies and Methods of Use
Roche Glycart AG
0 cites
US122583712025
Stabilized Immunoglobulin Domains
Hoffman-la Roche Inc.
0 cites
US122151522025
Humanized Anti-human CD19 Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US122151552025
Antibodies Binding to CD3 and CD19
Hoffmann-la Roche Inc.
0 cites
US122028702025
Antigen Binding Molecules Comprising a Trimeric TNF Family Ligand and Encoding Polynucleotides Thereof
Hoffmann-la Roche Inc.
0 cites
US121395532024
T Cell Activating Bispecific Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US121293062024
Antibodies Binding to STEAP-1
Hoffman-la Roche Inc.
0 cites
US121039822024
T Cell Activating Bispecific Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US120982132024
Antibodies Binding to HLA-A2/WT1
Hoffmann-la Roche Inc.
0 cites
US120384412024
CAR-T Reporter Based Diagnostic Assays to Detect Tumor Antigens in Cancer Patients
Hoffmann-la Roche Inc.
0 cites
US120000642024
Universal Reporter Cell Assay for Specificity Test of Novel Antigen Binding Moieties
HOFFMANN-LA ROCHE Inc.
0 cites
US119936422024
Trivalent, Bispecific Antibodies
Hoffmann-la Roche Inc.
0 cites
US119524212024
Bispecific Antibodies Against CD3EPSILON and ROR1
Bristol-myers Squibb Company
0 cites
US117878732023
Bispecific HER2 Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US117882052023
Car-t Cell Assay for Specificity Test of Novel Antigen Binding Moieties
0 cites
US117809192023
Bispecific Antigen Binding Molecules Targeting OX40 and FAP
Hoffmann-la Roche Inc.
0 cites
US117809202023
Antibodies Binding to CD3 and CD19
Hoffmann-la Roche Inc.
0 cites
US116857902023
Antibodies Binding to STEAP-1
Hoffmann-la Roche Inc.
0 cites
US116791272023
Antigen Binding Receptors Specific for Mutated Fc Domains
Hoffmann-la Roche Inc.
0 cites
US116728582023
Bispecific Antibody Molecules Binding to CD3 and TYRP-1
Hoffmann-la Roche Inc.
0 cites
US116083762023
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US115913972023
Bispecific Antibody Molecules Binding to CD3 and Egfrviii
Hoffmann-la Roche Inc.
0 cites
US115835752023
Mhc-bound Peptide Arrays and Methods of Use Thereof
Hoffmann-la Roche Inc.
0 cites
US115724042023
Humanized Anti-tau(ps422) Antibodies and Methods of Use
Hoffman-la Rocher Inc.
0 cites